Leap Therapeutics, Inc. (LPTX)
NASDAQ: LPTX · Real-Time Price · USD
0.4785
+0.0109 (2.33%)
At close: Oct 24, 2025, 4:00 PM EDT
0.4825
+0.0040 (0.84%)
After-hours: Oct 24, 2025, 7:35 PM EDT
Leap Therapeutics Market Cap
Leap Therapeutics has a market cap or net worth of $27.11 million as of October 24, 2025. Its market cap has decreased by -70.47% in one year.
Market Cap
27.11M
Enterprise Value
9.05M
1-Year Change
-70.47%
Ranking
Category
Stock Price
$0.48
Market Cap Chart
Since January 25, 2017, Leap Therapeutics's market cap has decreased from $73.80M to $27.11M, a decrease of -63.27%. That is a compound annual growth rate of -10.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2025 | 19.40M | -82.40% |
| Dec 31, 2024 | 110.20M | 3.96% |
| Dec 29, 2023 | 106.00M | 137.67% |
| Dec 30, 2022 | 44.60M | -84.42% |
| Dec 31, 2021 | 286.20M | 113.26% |
| Dec 31, 2020 | 134.20M | 395.20% |
| Dec 31, 2019 | 27.10M | -7.82% |
| Dec 31, 2018 | 29.40M | -49.83% |
| Dec 29, 2017 | 58.60M | -20.60% |
| Jan 25, 2017 | 73.80M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 729.35B |
| Johnson & Johnson | 464.66B |
| AbbVie | 403.98B |
| UnitedHealth Group | 327.39B |
| AstraZeneca | 259.95B |
| Novartis AG | 255.24B |
| Novo Nordisk | 237.27B |
| Abbott Laboratories | 222.69B |